Receive Promise magazine online to learn about the innovative research and excellent medical care happening at St. Jude. Your free subscription will start with our next quarterly issue of Promise.
In this issue . . .
Neurological Disorders: A New Direction
The Pediatric Translational Neuroscience Initiative (PTNI) at St. Jude joins basic and clinical research, hospital collaborations, and pharmaceutical partnerships to bring treatments to children with neurological diseases.
Portrait of a Scientist
Molecular oncologist Martine Roussel, PhD, is the first woman to receive the honor of being part of a venerable portrait gallery at St. Jude.
Science of Childhood Cancer: Conversations that Connect
Scientists at St. Jude haven’t allowed the pandemic to keep the cancer research community apart. Instead, they are using technology to find ways to connect virtually.
In Search of Hidden Gems: Data-Driven Discovery
With the world’s top talent and technology in place, St. Jude is using data-driven discovery to better understand childhood cancer and to identify promising drug targets.
The Global Alliance: Family, Home and Hope
The St. Jude Global Alliance empowers its members to improve care worldwide.
Our St. Jude App: St. Jude at Your Fingertips
The Our St. Jude mobile phone app guides patients and families, easing their load.
Biostatistics: Power Behind the Protocol
Who provides fuel for the engine of medical research — helping design studies, analyze data and report results? Biostatisticians.
HPV: Prevention is Key
The new St. Jude HPV Cancer Prevention Program seeks to increase HPV vaccination rates to help reduce the number of deaths from six types of cancer.
Life after St. Jude: Faith, Life, Laughter
Cancer survivor John Rose offers support and advice.
The Domino's Village
Construction has begun on a new six-story housing facility for St. Jude patients and families. The facility is scheduled to open in spring 2023.
News & Highlights - Spring 2021
Explore some of the latest clinical and scientific research from St. Jude, including medulloblastoma, COVID-19 and data sharing.